Articles published in Clinical Infectious Diseases: Open Access have been cited by esteemed scholars and scientists all around the world.
Clinical Infectious Diseases: Open Access has got h-index 3, which means every article in Clinical Infectious Diseases: Open Access has got 3 average citations.
Following are the list of articles that have cited the articles published in Clinical Infectious Diseases: Open Access.
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Total published articles |
29 | 23 | 5 |
Conference proceedings |
0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
4 | 4 | 1 |
| Journal total citations count | 49 |
| Journal impact factor | 1.2 |
| Journal 5 years impact factor | 0.14 |
| Journal cite score | 0.14 |
| Journal h-index | 3 |
| Journal h-index since 2019 | 2 |
Péchiné, Séverine, Claire Janoir, and Anne Collignon. "Emerging monoclonal antibodies against Clostridium difficile infection." Expert opinion on biological therapy 17, no. 4 (2017): 415-427. |
|
Prabhu, Vimalanand S., Oliver A. Cornely, Yoav Golan, Erik R. Dubberke, Sebastian M. Heimann, Mary E. Hanson, Jane Liao, Alison Pedley, Mary Beth Dorr, and Stephen Marcella. "Thirty-day readmissions in hospitalized patients who received bezlotoxumab with antibacterial drug treatment for Clostridium difficile infection." Clinical Infectious Diseases 65, no. 7 (2017): 1218-1221. |
|
Negm, Ola H., B. MacKenzie, M. R. Hamed, O. A. J. Ahmad, Clifford C. Shone, D. P. Humphreys, K. Ravi Acharya et al. "Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration." Clinical & Experimental Immunology 188, no. 3 (2017): 437-443. |
|
Chapin, Ryan W., Tiffany Lee, Christopher McCoy, Carolyn D. Alonso, and Monica V. Mahoney. "Bezlotoxumab: could this be the answer for Clostridium difficile recurrence?." Annals of Pharmacotherapy 51, no. 9 (2017): 804-810. |
|
Rees, William D., and Theodore S. Steiner. "Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy." European journal of immunology 48, no. 3 (2018): 398-406. |
|
Kufel, Wesley D., Aaron S. Devanathan, Ashley H. Marx, David J. Weber, and Lindsay M. Daniels. "Bezlotoxumab: a novel agent for the prevention of recurrent Clostridium difficile infection." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37, no. 10 (2017): 1298-1308. |
|
Goldstein, E. J. C., S. J. Johnson, P-J. Maziade, C. T. Evans, J. C. Sniffen, M. Millette, and L. V. McFarland. "Probiotics and prevention of Clostridium difficile infection." Anaerobe 45 (2017): 114-119. |
|
Navalkele, Bhagyashri D., and Teena Chopra. "Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection." Biologics: targets & therapy 12 (2018): 11. |
|
Song, Jung Hoon, and You Sun Kim. "Recurrent Clostridium difficile infection: risk factors, treatment, and prevention." Gut and liver 13, no. 1 (2019): 16. |
|
Varshney, Avanish K., Galina A. Kuzmicheva, Jian Lin, Kevin M. Sunley, Rodney A. Bowling Jr, Tzu-Yu Kwan, Heather R. Mays et al. "A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia." PLoS One 13, no. 1 (2018): e0190537. |
|
Kelly, Brendan J., and Pablo Tebas. "Clinical practice and infrastructure review of fecal microbiota transplantation for Clostridium difficile infection." Chest 153, no. 1 (2018): 266-277. |
|
Hui, Wenjia, Ting Li, Weidong Liu, Chunyan Zhou, and Feng Gao. "Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis." PloS one 14, no. 1 (2019): e0210016. |
|
Gupta, Swati B., Vinay Mehta, Erik R. Dubberke, Xuemei Zhao, Mary Beth Dorr, Dalya Guris, Deborah Molrine et al. "Antibodies to toxin B are protective against Clostridium difficile infection recurrence." Clinical Infectious Diseases 63, no. 6 (2016): 730-734. |
|
Clinical Infectious Diseases: Open Access received 49 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 